characteristics.text: SAMN22081064
characteristics.characteristic: External Id
characteristics.text: AREA Science Park
characteristics.characteristic: INSDC center name
characteristics.text: 2024-09-30T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-09-30T04:18:03.100Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS10460544
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS10460544
characteristics.characteristic: SRA accession
characteristics.text: 86
characteristics.characteristic: age
characteristics.text: Dept. of Medicine, Surgery and Neurosciences, University of Siena, Policlinico S. Maria alle Scotte-Siena
characteristics.characteristic: biomaterial_provider
characteristics.text: enriched B cells
characteristics.characteristic: cell_type
characteristics.text: CLL-B cells activated with CD40L feeder cells, anti-IgM and IL-4/21 replica 2
characteristics.characteristic: description
characteristics.text: Chronic lymphocytic leukemia
characteristics.characteristic: disease
characteristics.text: I/A
characteristics.characteristic: disease_stage
characteristics.text: CLL, mutated IGHV
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: biological replicate 2
characteristics.characteristic: replicate
characteristics.text: cell culture
characteristics.characteristic: sample_type
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Blood
characteristics.characteristic: tissue
characteristics.text: C2
characteristics.characteristic: title
characteristics.text: CD40L feeder cells, anti-IgM and IL-4/21
characteristics.characteristic: treatment